<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01305161</url>
  </required_header>
  <id_info>
    <org_study_id>I09010</org_study_id>
    <nct_id>NCT01305161</nct_id>
  </id_info>
  <brief_title>Flow Cytometry Applied to the Diagnosis of Peri-anaesthesic Reactions</brief_title>
  <acronym>CYPREANE</acronym>
  <official_title>Diagnostic Accuracy of Flow Cytometry Applied to the Diagnosis of Peri-anaesthesic Reactions Induced by Neuromuscular Blockers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess diagnostic accuracy of flow cytometry applied to the diagnosis of allergy to
      neuro-muscular blockers and to the determination of the neuro-muscular blocker (NMB) which
      may be used for an ulterior anaesthesia in case of allergy to one given NMB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The flow cytometric protocol used for this study, was based on basophil selection by an anti-
      CCR3 and the analysis of basophil activation by the respective up and down regulation of the
      CD63 and IgE markers as described previously. Basophil activation was expressed in percentage
      CD63 expression on activated basophils and in activation index involving IgE and CD63 markers
      and calculated by a specific algorithm developed by our group.. Our aim is to test a
      sufficient number of patients in order to be able to establish the ROC curves related to the
      allergen type tested and validate the use of an allergen mixture (NMB mix containing the 7
      usual NMB at the optimal activation concentrations). Patients will be included during the
      post-anaesthetic consultation on the basis of the diagnosis of an IgE dependant
      per-anaesthetic reaction. The allegro-anaesthetist diagnostical habits won't be changed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Allergy diagnosis assessed by cytometry flow data</measure>
    <time_frame>At Day 1</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">212</enrollment>
  <condition>Allergy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood simple</intervention_name>
    <description>Single Blood simple at Day 1</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged at least 18 years,

          -  patients having experienced an IgE dependant per-anaesthetic reaction

          -  affiliated to a social security

        Exclusion criteria:

          -  patients having taken anti-histamine drugs and corticoids during the last 8 days

          -  patients submitted to a juridical protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean SAINTE-LAUDY, MD</last_name>
    <phone>05.55.05.61.84</phone>
    <email>jean.sainte-laudy@chu-limoges.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service d'Allergologie</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mireille DROUET, MD</last_name>
      <email>midrouet@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Mireille DROUET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles RENIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Immuno-allergologie</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stéphane GUEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laboratoire Immunologie et Immunogénétique</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean SAINTE-LAUDY, MD</last_name>
      <phone>05.55.05.61.84</phone>
      <email>jean.sainte-laudy@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle Orsel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie Réanimation</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michel MERTES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudie MOUTON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chantal KOHLER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2011</study_first_submitted>
  <study_first_submitted_qc>February 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2011</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>1Allergy</keyword>
  <keyword>2 Neuromuscular blockers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Blocking Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

